Latest Advertising News

Medallion Metals has secured a positive EPBC Referral decision for its Ravensthorpe Gold Project, marking a crucial milestone in its sulphide development strategy. The company aims to submit additional environmental data by March 2025, targeting final approval by Q3 2025 while progressing drilling and financing.

News Corporation reported a robust half-year performance with revenues up 4% to $4.33 billion and net income soaring 80% to $334 million, while advancing its strategic pivot through the planned sale of Foxtel.

Aspermont reports its 34th consecutive quarter of subscription growth, with Annual Recurring Revenue rising to $11.4 million and promising new revenue streams emerging in advertising and live events.

News Corporation reported a robust second quarter for Fiscal 2025, with revenues climbing 5% to $2.24 billion and net income soaring 58%, while announcing the strategic sale of Foxtel to DAZN for A$3.4 billion.

REA Group has reported a robust half-year performance for H1 FY25, with revenue climbing 20% to $873 million and net profit surging 26%, driven by strong Australian and Indian market momentum and strategic technology investments.

REA Group has delivered a robust first half FY25 performance, posting a 20% revenue increase and a 26% rise in net profit, underpinned by strong Australian and Indian market growth. The company also announced a 26% higher interim dividend, signaling confidence in its ongoing momentum.

REA Group Ltd has delivered a robust half-year performance, reporting a 20% increase in revenue to $872.9 million and a 26% rise in net profit after tax to $313.9 million, driven by strong growth in both Australian and Indian markets.

REA Group announces CEO Owen Wilson will retire in the second half of 2025, concluding a decade marked by strong growth and innovation. The board has commenced a search for his successor to ensure a seamless leadership transition.

Rewardle Holdings Limited reported a robust net cash inflow from operating activities of $3.98 million for Q4 2024, offsetting significant investing outflows and ending the quarter with $1.23 million in cash.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Atomos Limited reported a 7% increase in Q2 FY25 sales driven by its core Shinobi II product, but faced margin pressures due to discounting and competitive pricing. The company is finalizing a cost restructure and reviewing funding options to support future growth.

Carly Holdings Limited has reported a 41% jump in customer receipts and its highest-ever subscription revenue in the December 2024 quarter, alongside significant cost reductions and strategic fleet adjustments.